Diane Beatty, PhD, VP of Regulatory and Clinical Affairs, and Kelly Porterfield, Director of Clinical Operations, will be participating in the European Conference on Interventional Oncology (ECIO) in Rotterdam, Netherlands, from April 13 to 16.  They will be accompanied by Lu Alleruzzo, CEO, and Tomas Hode, PhD, CIO & President. This prestigious event is one of the largest platforms for interventional oncology globally, and they are eager to connect with fellow professionals.

Visit our team at Booth #02 for an opportunity to learn more about how Immunophotonics continues to explore the ability of IP-001 to transform a routine interventional-oncology procedure into a systemic immunotherapy against cancer.